[Evolution of adherence to guidelines for prevention of group B streptococcal infections]

J Gynecol Obstet Biol Reprod (Paris). 2010 Nov;39(7):569-74. doi: 10.1016/j.jgyn.2010.07.008. Epub 2010 Sep 25.
[Article in French]

Abstract

Objective: Assess the evolution in implementation of neonatal group B streptococcal infections prevention program in the Aurore network, between 2004 and 2009.

Patients and methods: A cross-sectional study was conducted during one week in the whole maternity units of the Aurore network about implementation of the neonatal streptococcal infection prevention program. Deliveries occurring after 37 weeks of gestation were included. Every stage required by the prevention program was registered for every delivery. Results obtained during this study were compared with those obtained in 2004.

Results: Seven hundred and forty-four patients were included in 2004 and 618 in 2009. Vaginal swab rate was 96.3% in 2009 and 91.1% in 2004 (P<0.001), with a positive rate of 10.2 and 14.2%, respectively (P=0.041). Antibiotic infusion rates during delivery did not increase significantly. Clinical and biological surveillance of exposed newborns was significantly increased (P<0.001). No neonatal infection was observed during the study among newborns included in the program.

Conclusion: Sensitization of caregivers about neonatal streptococcal infection prevention seems to be efficient to increase the application of the prevention program written by the Aurore network.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Cross-Sectional Studies
  • Delivery, Obstetric
  • Female
  • France
  • Gestational Age
  • Guideline Adherence*
  • Health Plan Implementation
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Practice Guidelines as Topic
  • Pregnancy
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / prevention & control*
  • Streptococcal Infections / transmission
  • Streptococcus agalactiae* / isolation & purification
  • Vagina / microbiology

Substances

  • Anti-Bacterial Agents